In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kipchu Tshering, Mir Misbahuddin
Format: Artigo
Langue:Inglês
Publié: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Collection:Bangabandhu Sheikh Mujib Medical University Journal
Sujets:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Accès en ligne:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires